Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Revvity Inc. (RVTY : NYSE)
 
 • Company Description   
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.

Number of Employees: 11,000

 
 • Price / Volume Information   
Yesterday's Closing Price: $110.47 Daily Weekly Monthly
20 Day Moving Average: 1,252,810 shares
Shares Outstanding: 111.56 (millions)
Market Capitalization: $12,324.01 (millions)
Beta: 1.09
52 Week High: $118.30
52 Week Low: $81.22
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -2.26% -3.02%
12 Week 27.45% 24.32%
Year To Date 14.18% 5.45%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
77 4TH AVENUE
-
WALTHAM,MA 02451
USA		 ph: 781-663-6900
fax: 781-663-5985		 steve.willoughby@revvity.com http://www.revvity.com
 
 • General Corporate Information   
Officers
Prahlad Singh - President and Chief Executive Officer
Maxwell Krakowiak - Senior Vice President and Chief Financial Officer
Anita Gonzales - Vice President and Chief Accounting Officer
Peter Barrett - Director
Samuel R. Chapin - Director

Peer Information
Revvity Inc. (CHCR)
Revvity Inc. (ESRX)
Revvity Inc. (MYDP)
Revvity Inc. (COR)
Revvity Inc. (GBCS)
Revvity Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 714046109
SIC: 3826
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/26
Next Expected EPS Date: 08/04/26
Share - Related Items
Shares Outstanding: 111.56
Most Recent Split Date: 6.00 (2.00:1)
Beta: 1.09
Market Capitalization: $12,324.01 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.25%
Current Fiscal Quarter EPS Consensus Estimate: $1.30 Indicated Annual Dividend: $0.28
Current Fiscal Year EPS Consensus Estimate: $5.25 Payout Ratio: 0.05
Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: 0.01
Estmated Long-Term EPS Growth Rate: 9.68% Last Dividend Paid: 07/17/2026 - $0.07
Next EPS Report Date: 08/04/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 21.04
Trailing 12 Months: 21.58
PEG Ratio: 2.17
Price Ratios
Price/Book: 1.72
Price/Cash Flow: 12.53
Price / Sales: 4.25
EPS Growth
vs. Year Ago Period: 4.95%
vs. Previous Quarter: -37.65%
Sales Growth
vs. Year Ago Period: 6.97%
vs. Previous Quarter: -7.89%
ROE
06/30/26 - -
03/31/26 - 8.00
12/31/25 - 7.92
ROA
06/30/26 - -
03/31/26 - 4.83
12/31/25 - 4.81
Current Ratio
06/30/26 - -
03/31/26 - 1.72
12/31/25 - 1.68
Quick Ratio
06/30/26 - -
03/31/26 - 1.41
12/31/25 - 1.40
Operating Margin
06/30/26 - -
03/31/26 - 20.23
12/31/25 - 20.66
Net Margin
06/30/26 - -
03/31/26 - 8.26
12/31/25 - 8.45
Pre-Tax Margin
06/30/26 - -
03/31/26 - 9.16
12/31/25 - 9.39
Book Value
06/30/26 - -
03/31/26 - 64.24
12/31/25 - 63.95
Inventory Turnover
06/30/26 - -
03/31/26 - 3.45
12/31/25 - 3.38
Debt-to-Equity
06/30/26 - -
03/31/26 - 0.37
12/31/25 - 0.36
Debt-to-Capital
06/30/26 - -
03/31/26 - 26.82
12/31/25 - 26.63
 

Powered by Zacks Investment Research ©